Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients.
作者信息
Wu Tzong-Yow, Chen Pao-Yu, Wang Jann-Tay, Liu Wang-Da, Chen Yee-Chun, Chang Shan-Chwen
机构信息
Department of Internal Medicine, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan.
Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
出版信息
J Antimicrob Chemother. 2024 May 2;79(5):1196-1200. doi: 10.1093/jac/dkae082.
PMID:38538154
Abstract
摘要
Zotero 插件